share_log

華領醫藥-B:更改香港主要營業地點的地址

HUA MEDICINE-B: CHANGE OF ADDRESS OF PRINCIPAL PLACE OFBUSINESS IN HONG KONG

HKEX ·  Jul 19 16:30

Summary by Futu AI

華領醫藥-B(2552)宣布,自2024年7月19日起,公司將更改其在香港的主要營業地點。新的辦公地址將從香港灣仔軒尼詩道36號循道衛理大廈2202室遷至香港灣仔軒尼詩道200號恒生灣仔大廈506室。此公告由行政總裁兼執行董事陳力博士代表董事會發出。
華領醫藥-B(2552)宣布,自2024年7月19日起,公司將更改其在香港的主要營業地點。新的辦公地址將從香港灣仔軒尼詩道36號循道衛理大廈2202室遷至香港灣仔軒尼詩道200號恒生灣仔大廈506室。此公告由行政總裁兼執行董事陳力博士代表董事會發出。
Huaying Pharmaceutical-B (2552) announced that starting from July 19, 2024, the company will change its main place of business in Hong Kong. The new office address will be relocated from Room 2202, United Centre, 36 Harbour Road, Wan Chai, Hong Kong to Room 506, Hang Seng Wan Chai Building, 200 Hennessy Road, Wan Chai, Hong Kong. This announcement is issued by Dr. Chen Li, CEO and executive director, on behalf of the board of directors.
Huaying Pharmaceutical-B (2552) announced that starting from July 19, 2024, the company will change its main place of business in Hong Kong. The new office address will be relocated from Room 2202, United Centre, 36 Harbour Road, Wan Chai, Hong Kong to Room 506, Hang Seng Wan Chai Building, 200 Hennessy Road, Wan Chai, Hong Kong. This announcement is issued by Dr. Chen Li, CEO and executive director, on behalf of the board of directors.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.